Cagrilinitide 50mg & Semaglutide 50mg

Original price was: $ 1.000.00.Current price is: $ 500.00.

The Cagrilintide and Semaglutide combo is a dual-peptide therapy designed to enhance weight loss and improve metabolic control by combining the appetite-suppressing effects of Cagrilintide with the glucose-regulating and satiety-promoting effects of Semaglutide.

Category

Substance

Cagrilinitide & Semaglutide

Dosage

100mg 10x5mg/5mg

Manufacturer

AP Labs

Warehouse

Bulk Peptides

  •  Delivery & Return

    Delivery


    Turkish Pharmacy - $50 shipping cost.
    Minimum order $200.

    Indian Pharmacy - $35 shipping cost.
    Minimum order - $150.

    US Domestic - All 3 US locations have $15 shipping cost EACH.
    US Pharma - $150 minimum order.
    US Peptides/HGH - $150 minimum order.
    Oils & Tablets - $200 minimum order.

    For extensive information about delivery read more here...
  ... people are viewing this right now

  Share
! READ BEFORE ORDERING !

    The Cagrilintide + Semaglutide combination is a novel therapeutic approach in obesity and metabolic management, leveraging the complementary mechanisms of two peptides:

    1. Cagrilintide – a long-acting amylin analog that suppresses appetite, slows gastric emptying, and enhances satiety.
    2. Semaglutide – a GLP-1 receptor agonist that improves insulin sensitivity, reduces appetite, and promotes glucose regulation.

    Mechanisms and synergistic effects:

    • Enhanced appetite suppression: Both peptides reduce food intake through complementary central pathways, increasing satiety signals.
    • Improved weight loss: Clinical studies show that the combination results in greater body weight reduction compared to either agent alone.
    • Metabolic benefits: Semaglutide improves blood glucose regulation and insulin sensitivity, while Cagrilintide enhances post-meal satiety and fat metabolism.
    • Cardiometabolic support: Together, they may improve lipid profiles, reduce visceral fat, and support overall metabolic health.

    The therapy is typically administered via subcutaneous injection, often once weekly or according to clinical protocols. Early clinical trials suggest the combination is well-tolerated, with common side effects including mild gastrointestinal symptoms such as nausea or vomiting, which usually decrease over time.

    In summary, the Cagrilintide + Semaglutide combo is a synergistic peptide-based therapy that targets weight management, appetite regulation, and metabolic control, offering a promising approach for individuals with obesity or type 2 diabetes.

    My Cart
    Wishlist
    Recently Viewed
    Categories

    Wait! before you leave...

    Join our community for the latest news and updates


      Subscribe for our Wholesale Deals